Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.

Vantelon, J M; Munck, J N; Bourhis, J H; Pico, J L; Fadel, C; Ulusakarya, A; Carde, P; Fenaux, P; Ribrag, V

Vantelon, J M; Munck, J N; Bourhis, J H; Pico, J L; Fadel, C; Ulusakarya, A; Carde, P; Fenaux, P; Ribrag, V.

Affiliation

Vantelon JM; Department of Medicine, Institut Gustave Roussy, Villejuif, France.

Bone Marrow Transplant ; 27(5): 531-6, 2001 Mar.

Article in En | MEDLINE | ID: mdl-11313688

Subject(s)

Anemia, Hemolytic/chemically induced; Thrombosis/chemically induced; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/toxicity; Drug Administration Schedule; Endothelium, Vascular/drug effects; Endothelium, Vascular/pathology; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma/complications; Lymphoma/drug therapy; Male; Middle Aged; Pilot Projects; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Anemia, Hemolytic Limits: Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2001 Document type: Article

Search on Google

XML

PubMed Links